[Chronic senile cerebrovascular insufficiency. Effects of suloctidil and pentoxifylline on erythrocyte deformability]
[Article in
Italian]
- PMID: 6324325
Item in Clipboard
[Chronic senile cerebrovascular insufficiency. Effects of suloctidil and pentoxifylline on erythrocyte deformability]
[Article in
Italian]
Ric Clin Lab.
1983.
Abstract
Red blood cell filtration, platelet aggregation, serum triglyceride and cholesterol levels were investigated in 15 patients with chronic cerebrovascular disease, 10 of whom treated with Suloctidil and 5 with pentoxifylline. The treatment was carried out in 90 days. Both pentoxifylline and Suloctidil produced a significant improvement of erythrocyte deformability and a decrease of platelet aggregation.
Similar articles
-
[Hemorrheological survey in a group with arteriosclerotic vascular disease treated with suloctidil].Ric Clin Lab. 1983;13 Suppl 3:465-8. Ric Clin Lab. 1983. PMID: 6324326 Italian.
-
Suloctidil: long-term trial in the aged. Study of microcirculation, viscosity, red cell deformability, fibrinolysis and lipid fractions.Arzneimittelforschung. 1985;35(5):855-7. Arzneimittelforschung. 1985. PMID: 2992530 Clinical Trial.
-
Effects of long-term treatment with suloctidil on blood viscosity, erythrocyte deformability and total fibrinogen plasma levels in diabetic patients.Arzneimittelforschung. 1979;29(4):682-4. Arzneimittelforschung. 1979. PMID: 582768 Clinical Trial.
-
Cerebrovascular circulatory disorders: new aspects of pathophysiology and therapy.J Med. 1979;10(5):347-64. J Med. 1979. PMID: 393790 Review.
-
Pentoxifylline -- a biomedical profile.J Med. 1979;10(5):307-29. J Med. 1979. PMID: 393789 Review.
Cited by
-
Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy.Drugs. 1987 Jul;34(1):50-97. doi: 10.2165/00003495-198734010-00003. Drugs. 1987. PMID: 3308412 Review.